Dermatomyositis overlapping with Rheumatoid arthritis: a rare clinical entity
Journal Title: JOURNAL OF MEDICAL COLLEGE CHANDIGARH - Year 2016, Vol 6, Issue 2
Abstract
The association of dermatomyositis with rheumatoid arthritis (RA) is described in a 46 year old patient who was studied over a period of one year. Our patient had both diseases simultaneously overlapping with each other. His ACR score was 8 confirming diagnosis of RA and his classical rash on face, proximal muscle weakness, significantly elevated creatinine phosphokinase (CPK) levels and electromyography (EMG) and magnetic resonance imaging (MRI) findings confirmed the diagnosis of Dermatomyositis. Areview of literature revealed few specific reports of coexistence of both diseases.
Authors and Affiliations
Mandip Singh Bhatia, Ritu Attri, Monica Gupta
Keywords
Related Articles
- EP ID EP328402
- DOI -
- Views 135
- Downloads 0
Circumcaval ureters can present late in life: A report of two cases with review of literature
Circumcaval or retrocaval ureter is a rare congenital anomaly with ureter passing dorsal to inferior vena cava (IVC) and more appropriately termed as preureteral vena cava (PVC). Although, it is a congenital anomaly but...
Difficult airway in a patient with Wegener's Granulomatosis - a case report
Wegener's Granulomatosis is an immunologically mediated multi-system disease of unknown etiology. It is characterized by the triad of necrotizing granulomas of the upper and lower respiratory tract, focal necrotizing glo...
Anaesthetic management and concerns in patient with post-polio syndrome
Poliomyelitis is a neuromuscular disorder which selectively damages motor and autonomic nervous systems. Anaesthetic management in patient with post-polio syndrome (PPS) have many crucial concerns and requires comprehens...
Current trend in medical expulsive therapy (MET) for the treatment of ureteral stones
Medical expulsive therapy (MET) has been described as an effective conservative treatment option for small ureteral stones. The agents that have been investigated include NASAIDs, corticosteroids, calcium channel blocker...
Lixisenatide: GLP-1 (glucagon like peptide) analogue for type 2 diabetes mellitus
GLP-1 analogues increase insulin sensitivity and decrease hepatic gluconeogenesis, thereby bringing down the blood sugar levels. Lixisenatide is the newest of the GLP-1 analogues to get USFDA approval for its use in the...